-
IntroducedJan 05, 2024
-
Passed HouseJun 13, 2024
-
Passed Senate
-
Signed into Law
AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.)
Last Action See all actions
House • Jun 13, 2024: 06/13/2024 House passed as amended (floor amendment)
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 7041
Tweets
Whip Lists
Sponsors
Votes
YES: 70
- Abney
- Ackerman
- Ajello
- Alzate
- Azzinaro
- Baginski
- Batista
- Bennett
- Biah
- Blazejewski
- Boylan
- Brien
- Caldwell
- Cardillo
- Carson
- Casey
- Casimiro
- Chippendale
- Cortvriend
- Corvese
- Costantino
- Cotter
- Craven
- Cruz
- Dawson
- DeSimone
- Diaz
- Donovan
- Edwards
- Felix
- Fellela
- Fenton-Fung
- Finkelman
- Fogarty
- Giraldo
- Handy
- Henries
- Hull
- Kazarian
- Kennedy
- Kislak
- Knight
- Lima
- Lombardi
- Marszalkowski
- McEntee
- McGaw
- McNamara
- Messier
- Morales
- K. Joseph Shekarchi
- Nardone
- O'Brien
- Perez
- Potter
- Quattrocchi
- Rea
- Roberts
- Sanchez
- Serpa
- ShallcrossSmith
- Shanley
- Slater
- Solomon
- Speakman
- Spears
- Stewart
- Tanzi
- Vella-Wilkinson
- Voas
NOT VOTING: 1
- Morgan
YES: 65
- Ackerman
- Ajello
- Alzate
- Azzinaro
- Batista
- Bennett
- Biah
- Blazejewski
- Caldwell
- Cardillo
- Carson
- Casey
- Casimiro
- Chippendale
- Cortvriend
- Corvese
- Costantino
- Cotter
- Craven
- Cruz
- Dawson
- DeSimone
- Diaz
- Donovan
- Edwards
- Felix
- Fellela
- Fenton-Fung
- Fogarty
- Giraldo
- Handy
- Henries
- Hull
- Kazarian
- Kennedy
- Kislak
- Knight
- Lima
- Lombardi
- Marszalkowski
- McEntee
- McGaw
- McNamara
- Messier
- Morales
- K. Joseph Shekarchi
- Nardone
- Newberry
- Noret
- Perez
- Phillips
- Place
- Potter
- Quattrocchi
- Rea
- Roberts
- Sanchez
- Serpa
- ShallcrossSmith
- Shanley
- Slater
- Solomon
- Speakman
- Stewart
- Vella-Wilkinson
NO: 0
Actions
- Jun 13, 2024 | House
- 06/13/2024 House passed as amended (floor amendment)
- Jun 12, 2024 | House
- 06/12/2024 Committee recommends passage
- 06/12/2024 Placed on House Calendar (06/13/2024)
- Jun 10, 2024 | House
- 06/10/2024 Scheduled for consideration (06/12/2024)
- Feb 29, 2024 | House
- 02/29/2024 Committee recommended measure be held for further study
- Feb 23, 2024 | House
- 02/23/2024 Scheduled for hearing and/or consideration (02/29/2024)
- Jan 29, 2024 | House
- 01/29/2024 Committee postponed at request of sponsor (01/30/2024)
- Jan 26, 2024 | House
- 01/26/2024 Scheduled for hearing and/or consideration
- Jan 05, 2024 | House
- 01/05/2024 Introduced, referred to House Health & Human Services
Bill Texts
Documents
- 01/29/2024 Committee postponed at request of sponsor (01/30/2024)
- 02/23/2024 Scheduled for hearing and/or consideration (02/29/2024)
- 06/10/2024 Scheduled for consideration (06/12/2024)
- 06/12/2024 Placed on House Calendar (06/13/2024)
- House Health and Human Services: 02-29-2024--H7041--Department of business RegulationPDF
- House Health and Human Services: 02-29-2024--H7041-H7042-H7140--AHIPPDF
- House Health and Human Services: 02-29-2024--H7041--HDAPDF
- House Health and Human Services: 02-29-2024--H7041--PHRMAPDF
- House Health and Human Services: 01-30-2024--H7041--HDA--Kelly MemphisPDF